Skip to main content
Clinical Trials/NCT04789083
NCT04789083CompletedNot Applicable

The Effect of Propolis in Tinea Pedis Treatment: A Randomized Controlled Study

Necmettin Erbakan University1 site in 1 country96 target enrollmentStarted: February 3, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
96
Locations
1
Primary Endpoint
Evaluation

Study Overview

Brief Summary

Tineapedis is an important health problem. Providing foot care in tinea pedis treatment contributes positively to the treatment. In addition, alternative treatments can also be used. In this study, the randomization study group will be divided into three. Medical treatment and foot care training will be applied to the first group, medical treatment and propolis to the second group, medical treatment and plassebo to the control group. Foot care training will be given by nurse coaching. Times of all three groups and their response to treatment will be evaluated.

Detailed Description

  1. Study Identification: Randomised Controlled Trial
  2. Study Status: This will begin
  3. Sponsor/Collaborators: SBS Scientific Bio Solutions Inc.
  4. Oversight: Patients will be given foot care training. At the same time, a phone call will be provided by the research nurse every week. Evaluation will be made at the end of 2 months
  5. Study Description

It was planned as a double-blind randomized controlled study. The person conducting the randomizer, the person making the statistics and the person performing the medical examiner will be blinded. Power analysis was made using the G * Power (3.1.9.4) program, 0.05 margin of error and 85% power were accepted. A total of 96 people were divided into three groups. Groups were composed of 36 people, including 10% losses for each group.

Inclusion Criteria:

Not being pregnant Not being breastfeeding Not having confusion Not being immunosuppressed Not using systemic cortisone Not having any dermatological problems (psoriasis, contact dermatitis, etc.) that will affect the treatment.

Agree to participate in research Being accessible by phone Having no problems communicating by phone Not having problems with physical care

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Not being pregnant
  • •Not being breastfeeding
  • •Not having confusion
  • •Not being immunosuppressed
  • •Not using systemic cortisone
  • •Not having any dermatological problems (psoriasis, contact dermatitis, etc.) that will affect the treatment.
  • •Agree to participate in research
  • •Being accessible by phone
  • •Having no problems communicating by phone
  • •Not having problems with physical care

Exclusion Criteria

  • •Pregnant / nursing women
  • •Using systemic antifungal therapy
  • •Using systemic croticosteroids
  • •In the process of treatment for oncological reasons
  • •Are using immunosuppressants
  • •Dermatological disease (contact dermatitis, psoriasis)
  • •Under the age of 18 and over the age of 64
  • •Have cognitive problems
  • •There is no telephone / telephone number within reach
  • •Individuals who have difficulties in speaking and understanding Turkish will be excluded from the study.

Arms & Interventions

Group 1 (Propolis)

Experimental

Medical therapy and propolis

Intervention: Propholis extrate (Other)

Group 2 (Nurse Coaching/ Nursing education)

Experimental

Medical treatment and nurse coaching

Intervention: Propholis extrate (Other)

Group 3 (Plassebo)

Placebo Comparator

Medical treatment and plassebo will be applied.

Intervention: Propholis extrate (Other)

Outcomes

Primary Outcomes

Evaluation

Time Frame: 3 month

Dermatological Quality of Life Scale

Secondary Outcomes

  • Doctor's an patient's global(3 month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rukiye Burucu

Assit. Prof.

Necmettin Erbakan University

Study Sites (1)

Loading locations...

Similar Trials